呼吸道同胞性病毒疫苗接种:可能和不太可能的结果
Current opinion in pediatrics
|March 19, 2025
概括
新的疫苗和单克隆抗体为婴儿和老年人提供了对呼吸道同胞病毒 (RSV) 的显著保护. 虽然有效,但必须解决疫苗犹和接种等挑战,以获得广泛的影响.
科学领域:
- * 免疫学和传染病
- * 儿科和老年医学
背景情况:
- *呼吸道同胞病毒 (RSV) 是脆弱人群中严重呼吸道感染的主要原因.
- * 婴儿,老年人和免疫受损的个体患并发症的风险最高.
- *现有的预防方法有局限性,需要新的策略.
研究的目的:
- * 审查RSV预防的最新进展,包括新的疫苗和单克隆抗体.
- * 探索这些干预措施的直接和潜在的长期影响.
- * 确定RSV预防和控制的剩余挑战.
主要方法:
- *对最近的临床试验和流行病学数据进行了全面的文献综述.
- *对已批准和新兴的RSV预防策略进行分析.
- * 评估有效性,安全性和实施挑战.
主要成果:
- * 现在可以获得新的母体RSVPreF疫苗,婴儿单克隆抗体 (例如Nirsevimab) 和成人疫苗.
- *这些干预措施显示了RSV相关住院,ICU入院和死亡率的显著减少.
- *早期数据表明婴儿喘息减少,但对喘的长期影响仍在调查中.
结论:
- *RSV疫苗和单克隆抗体有望改变临床实践和公共卫生结果.
- *进一步的研究至关重要,以了解对喘和睡眠呼吸暂停等疾病的长期影响.
- *解决疫苗犹和确保公平的接种是全球RSV控制的关键.
更多相关视频
相关概念视频
Vaccinations
43.1K
Overview
43.1K
Common Respiratory Disorders
200
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
200
Pulmonary Cycle: Exhalation
1.3K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.3K
Acute Respiratory Failure-II
157
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
157
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
Acute Respiratory Failure-I
158
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
158


